Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of 122.00 billion as of June 26, 2025. Its market cap has increased by 6.38% in one year.

Market Cap

122.00B

Enterprise Value

136.93B

Revenue

22.16B

Ranking

n/a

PE Ratio

12.30

Stock Price

1,018.51

Market Cap Chart

Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 1.94B to 122.00B, an increase of 6,179.05%. That is a compound annual growth rate of 21.65%.

Market Cap History

Date	Market Cap	% Change
Jun 24, 2025	126.18B	-0.45%
Dec 31, 2024	126.75B	53.56%
Dec 29, 2023	82.54B	-45.00%
Dec 30, 2022	150.07B	29.37%
Dec 31, 2021	116.00B	1.13%
Dec 31, 2020	114.71B	134.71%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	1,096.67B
Grupo Financiero Banorte	477.64B
Arca Continental	335.61B
Industrias Peñoles	191.37B
GMéxico Transportes	142.90B
FIBRA Prologis	111.33B
Fibra UNO	98.94B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	88.71B

Market Cap Rankings